All Stories

  1. Complement inhibitors and B cell–modifying agents for IgA nephropathy—a Kidney Disease: Improving Global Outcomes (KDIGO) commentary

    Article • Kidney International, March 2026, Elsevier

    Brad Rovin

  2. Systematic Review and Meta-Analysis of Native Kidney Biopsy Complications

    Article • Clinical Journal of the American Society of Nephrology, October 2020, American Society of Nephrology

    Brad Rovin

  3. Urinary Soluble CD163: a Novel Noninvasive Biomarker of Activity for Lupus Nephritis

    Article • Journal of the American Society of Nephrology, April 2020, American Society of Nephrology

    Brad Rovin

  4. Calcineurin Inhibitors in the Treatment of Lupus Nephritis: A Hare Versus Turtle Story?

    Article • Journal of the American Society of Nephrology, October 2017, American Society of Nephrology

    Brad Rovin

  5. Identification, Confirmation, and Replication of Novel Urinary MicroRNA Biomarkers in Lupus Nephritis and Diabetic Nephropathy

    Article • Clinical Chemistry, June 2017, AACC

    Dr. Ian H de Boer, Brad Rovin

  6. The Pharmacogenomic Association of Fcγ Receptors and Cytochrome P450 Enzymes With Response to Rituximab or Cyclophosphamide Treatment in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

    Article • Arthritis & Rheumatology, December 2016, Wiley

    Brad Rovin

  7. Update on Lupus Nephritis

    Article • Clinical Journal of the American Society of Nephrology, November 2016, American Society of Nephrology

    Brad Rovin, Alexa Meara

  8. The interleukin-6-hepcidin-hemoglobin circuit in systemic lupus erythematosus flares

    Article • Lupus, July 2016, SAGE Publications

    Brad Rovin

  9. Predicting decline of kidney function in lupus nephritis using urine biomarkers

    Article • Lupus, July 2016, SAGE Publications

    Brad Rovin

  10. The impact of tabalumab on the kidney in systemic lupus erythematosus: results from two phase 3 randomized, clinical trials

    Article • Lupus, July 2016, SAGE Publications

    Brad Rovin

  11. Relationship of Circulating Anti-C3b and Anti-C1q IgG to Lupus Nephritis and Its Flare

    Article • Clinical Journal of the American Society of Nephrology, December 2015, American Society of Nephrology

    Brad Rovin

  12. Cross-Disciplinary Biomarkers Research: Lessons Learned by the CKD Biomarkers Consortium

    Article • Clinical Journal of the American Society of Nephrology, March 2015, American Society of Nephrology

    Dr Stephen M Hewitt, Chi-yuan Hsu, Brad Rovin, PhD Ilse Daehn Daehn

  13. The value of repeat kidney biopsy in quiescent Argentinian lupus nephritis patients

    Article • Lupus, January 2014, SAGE Publications

    Brad Rovin

  14. Renal Flare as a Predictor of Incident and Progressive CKD in Patients with Lupus Nephritis

    Article • Clinical Journal of the American Society of Nephrology, November 2013, American Society of Nephrology

    Brad Rovin

  15. Lupus Nephritis: Induction Therapy in Severe Lupus Nephritis—Should MMF Be Considered the Drug of Choice?

    Article • Clinical Journal of the American Society of Nephrology, August 2012, American Society of Nephrology

    Dr chi chiu mok, Dr Lai Senng Hooi, T M Chan, Brad Rovin